(17 references)-
- 抗原 See all CST3 抗体
- CST3 (Cystatin C (CST3))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This CST3 antibody is un-conjugated
-
应用范围
- ELISA, Immunohistochemistry (IHC)
- 特异性
- Specific for Human Cystatin C denatured and native forms
- 交叉反应
- 人
- 纯化方法
- Protein G purified
- 免疫原
- Recombinant Human Cystatin C protein
- 克隆位点
- 3A1B7
- 亚型
- IgG2b
- Top Product
- Discover our top product CST3 Primary Antibody
-
anti-Cystatin C (CST3) (AA 27-146) antibody
CST3 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Cystatin C (CST3) antibodyCST3 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
anti-Cystatin C (CST3) (AA 27-146) antibodyCST3 适用: 人 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C14 unconjugated
anti-Cystatin C (CST3) (AA 27-146) antibodyCST3 适用: 人 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C6 unconjugated
anti-Cystatin C (CST3) (AA 21-140) antibodyCST3 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Cystatin C (CST3) (AA 42-127) antibodyCST3 适用: Pig WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Cystatin C (CST3) antibodyCST3 适用: 人 WB, ELISA, IHC (p), IF 宿主: 小鼠 Monoclonal 3B6 unconjugated
anti-Cystatin C (CST3) antibodyCST3 适用: 人, 小鼠, 大鼠, 猴 WB, ELISA, IHC, ICC, IF 宿主: 兔 Polyclonal unconjugated
anti-Cystatin C (CST3) antibodyCST3 适用: 人 WB, IF 宿主: 小鼠 Monoclonal 1A6 unconjugated
anti-Cystatin C (CST3) antibodyCST3 适用: 人 WB, ELISA 宿主: 小鼠 Monoclonal 5H2 unconjugated
-
- 应用备注
- Recommended dilution:IHC:1:50-1:500,
- 说明
-
Other species are not tested. Please decide the specificity by homology
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 注意事项
- Avoid freeze and thaw cycles.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
: "Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients." in: Scandinavian journal of rheumatology, Vol. 40, Issue 5, pp. 341-6, (2011) (PubMed).
: "Serum cystatin C and microalbuminuria in the detection of vascular and renal damage in early stages." in: Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 31, Issue 5, pp. 560-6, (2011) (PubMed).
: "[Urinary cystatin C as a biomarker of renal tubular injury]." in: Postȩpy higieny i medycyny doświadczalnej (Online), Vol. 65, pp. 562-8, (2011) (PubMed).
: "[Cystatin C level is independently related to risk of unfavorable outcome after acute coronary syndrome in individuals with normal or moderately reduced renal function]." in: Kardiologiia, Vol. 51, Issue 6, pp. 4-10, (2011) (PubMed).
: "The effect of including cystatin C or creatinine in a cardiovascular risk model for asymptomatic individuals: the multi-ethnic study of atherosclerosis." in: American journal of epidemiology, Vol. 174, Issue 8, pp. 949-57, (2011) (PubMed).
: "Is cystatin C a useful marker in the detection of diabetic kidney disease?" in: Nephron. Clinical practice, Vol. 114, Issue 2, pp. c127-34, (2010) (PubMed).
: "Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease." in: Clinical chemistry, Vol. 56, Issue 5, pp. 740-9, (2010) (PubMed).
: "Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C." in: American journal of nephrology, Vol. 30, Issue 3, pp. 171-8, (2009) (PubMed).
: "Metabolic abnormalities are present in adults with elevated serum cystatin C." in: Kidney international, Vol. 76, Issue 1, pp. 81-8, (2009) (PubMed).
: "Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease." in: Clinical nephrology, Vol. 70, Issue 1, pp. 10-7, (2008) (PubMed).
: "Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa." in: Nephron. Clinical practice, Vol. 110, Issue 3, pp. c158-63, (2008) (PubMed).
: "Use of serum cystatin C to detect early decline of glomerular filtration rate in type 2 diabetes." in: Internal medicine (Tokyo, Japan), Vol. 46, Issue 12, pp. 801-6, (2007) (PubMed).
: "Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients." in: Clinical chemistry, Vol. 53, Issue 3, pp. 480-8, (2007) (PubMed).
: "Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function." in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 21, Issue 7, pp. 1855-62, (2006) (PubMed).
: "Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease." in: Annals of internal medicine, Vol. 145, Issue 4, pp. 237-46, (2006) (PubMed).
: "Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients." in: Kidney international, Vol. 61, Issue 4, pp. 1453-61, (2002) (PubMed).
: "Total parathyroidectomy and delayed parathyroid autotransplantation using a simplified cryopreservation technique: human and animal studies." in: American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 3, Issue 5, pp. 366-70, (1984) (PubMed).
-
: "Cystatin C concentration is correlated with disease activity in rheumatoid arthritis patients." in: Scandinavian journal of rheumatology, Vol. 40, Issue 5, pp. 341-6, (2011) (PubMed).
-
- 抗原
- CST3 (Cystatin C (CST3))
- 别名
- CST3 (CST3 产品)
- 别名
- armd11 antibody, fb51d07 antibody, wu:fb24g06 antibody, wu:fb51d07 antibody, wu:fc55f03 antibody, zgc:136227 antibody, ARMD11 antibody, CysC antibody, CYSC antibody, cystatin C antibody, cystatin C L homeolog antibody, cystatin C (amyloid angiopathy and cerebral hemorrhage) antibody, cystatin 3 antibody, CST3 antibody, cst3.L antibody, cst3 antibody, cystatin 3 antibody, Cst3 antibody
- 背景
-
Background: Defects in CST3 are the cause of amyloidosis type 6 (AMYL6) [MIM:105150], also known as hereditary cerebral hemorrhage with amyloidosis (HCHWA), cerebral amyloid angiopathy (CAA) or cerebroarterial amyloidosis Icelandic type. AMYL6 is a hereditary generalized amyloidosis due to cystatin C amyloid deposition. Cystatin C amyloid accumulates in the walls of arteries, arterioles, and sometimes capillaries and veins of the brain, and in various organs including lymphoid tissue, spleen, salivary glands, and seminal vesicles. Amyloid deposition in the cerebral vessels results in cerebral amyloid angiopathy, cerebral hemorrhage and premature stroke. Cystatin C levels in the cerebrospinal fluid are abnormally low.Genetic variations in CST3 are associated with age-related macular degeneration type 11 (ARMD11) [MIM:611953]. ARMD is a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane.
Aliases: CysC,Cystatin-3,Gamma-trace,Neuroendocrine basic polypeptide,Post-gamma-globulin
- UniProt
- P01034
-
You are here:
